BB Biotech
1993
FOUNDED
PUBLIC
STATUS
65
INVESTMENTS
$50.56
SHARE PRICE
(As of Thursday Closing)
Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the health care system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace.
Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Capital Markets/Institutions
Former Stock Listing
BIOEE
Primary Office
- Schwertstrasse 6
- 8200 Schaffhausen
- Switzerland
+41 052 000 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BB Biotech’s full profile, request a free trial.
BB Biotech Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $50.56 - $50.56 | $4.1B | $51.04 | $12.61 | 55.4M |
BB Biotech Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2018
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 3,372,676 | 3,372,676 | ||
| Revenue | (433,126) | (433,126) | 741,498 | (775,471) |
| Net Income | (481,650) | (481,650) | 698,285 | (813,883) |
| Total Assets | 3,135,316 | 3,135,316 | 3,734,561 | 3,166,641 |
| Total Debt | 187,905 | 187,905 | 97,527 | 201,213 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
BB Biotech Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore BB Biotech‘s full profile, request access.
Request full access to PitchBookBB Biotech Investments (65)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000000 | 01-Feb-2018 | 00000 00000 00 | 00000 | Drug Discovery | |
| 000000 00000000000 | 19-Oct-2017 | 0000 | 000.00 | Biotechnology | 000 0000000 |
| 000000 00000000000 | 01-Jun-2017 | 0000 | Biotechnology | 000 0000000 | |
| 00000 | 06-Dec-2016 | 00000 00000 00 | 000.00 | Surgical Devices | |
| Myovant Sciences | 27-Oct-2016 | IPO | 00000 | Biotechnology |
BB Biotech Exits (51)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 0000000000 | 01-Feb-2018 | 00000 00000 00 | 00000 | Completed |
|
| 000000 | 03-Sep-2015 | 00000 00000 00 | 000.00 | Completed |
|
| 0000 000000000000 | 01-Aug-2014 | 00000 00000 00 | 00000 | Completed |
|
| 0000 000000000000 | 11-Mar-2014 | 00000 00000 00 | 0000 | Completed |
|
| Intracellular Therapies | 03-Sep-2013 | Later Stage VC | 0000 | Completed |
|
BB Biotech Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore BB Biotech‘s full profile, request access.
Request full access to PitchBookBB Biotech Executive Team (16)
4 Former Executives
You’re viewing 5 of 16 executives. Get the full list »BB Biotech Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 00000000 00.0 | The Medicines Company | Vice Chairman | 000 0000 | |
| 00000 00000000 00.0 | Self | Chairman & President | 000 0000 | |
| 00000 000000 00.0 | Self | Member of the Board of Directors | 000 0000 | |
| 0000 00 00000 | BB Biotech | Board Member & Managing Director | 000 0000 |
1 Former Board Member
You’re viewing 4 of 5 board members. Get the full list »